Tilia Farma SRL
Tilia Farma reported total assets of 873,139 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
By total assets for 2025, Tilia Farma ranks in the top half of the 3,806 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Tilia Farma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +305 % Total assets +5 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tilia Farma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jun 2025
- Year ended 31 Dec 2023filed on 20 Aug 2024
Tilia Farma's financial analysis
- Solvency17.4%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tilia Farma
Tilia Farma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0802.954.023
- VAT number
- BE0802954023
- Peppol
- Registered · 0208:0802954023 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jun 2023
- Registered office
- 3960 Bree
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Tilia Farma (SRL) has been based in Bree since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 63,379 € and equity of 152,212 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Tilia Farma
Companies in the same business, of comparable size and area, outside its group.
- ANAP Retail sale of pharmaceutical products Aalst · balance sheet €1.37m
- Apotheek Sara Tsjoen Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet €1.25m
- Pharmacie Squelard Retail sale of pharmaceutical products Walcourt · balance sheet 819,721 €
- Lena Malcorps Retail sale of pharmaceutical products Sint-Truiden · balance sheet 704,130 €
- Dorothee Retail sale of pharmaceutical products Uccle · balance sheet 990,089 €
- Atte Gestion Retail sale of pharmaceutical products Ans · balance sheet 631,890 €
- Justine Gailliaert Retail sale of pharmaceutical products Jabbeke · balance sheet 614,717 €
- Mylle Pharma Retail sale of pharmaceutical products Anzegem · balance sheet 947,525 €
Frequently asked questions about Tilia Farma
What is the revenue of Tilia Farma?
Tilia Farma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tilia Farma?
In Belgium, the VAT number is the company number prefixed with BE: BE0802954023 for Tilia Farma, if the company is VAT-registered. Its company number (CBE) is 0802.954.023.
Where is the registered office of Tilia Farma?
According to the CBE register, the registered office of Tilia Farma is in 3960 Bree.
What is the equity of Tilia Farma?
At the close of the 2025 financial year, the equity of Tilia Farma amounts to 152,212 €, a solvency of 17.4% of total assets.
Who manages Tilia Farma?
The register lists 1 active mandates at Tilia Farma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Tilia Farma within its sector?
By total assets for 2025, Tilia Farma ranks in the top half of the 3,806 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Tilia Farma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →